Fibrobiologics Granted US Patent Covering The Use Of Fibroblasts

FBLG•2026-08-11

U.S. patent grant

Aug. 11 (Reuters) - Fibrobiologics Inc. FBLG.O said it was granted a U.S. patent covering the use of fibroblasts to enhance survival and function of transplanted insulin-producing islets.

Fibrobiologics Granted US Patent Covering The Use Of Fibroblasts

U.S. patent grant

Related News

D.E. Shaw discloses net short position in Abivax shares

Nasdaq trade halt continues <SVA.O> reason not available at 09:50 AM

Deals of the day-Mergers and acquisitions

Nasdaq Trade Halt <IPCXU.O> Volatility Trading Pause at 09:59 AM

TD SYNNEX expands IBM distribution partnership into 20 new countries